BOSTON, March 6, 2026 /PRNewswire/ -- Aisa Pharma, Inc., a clinical-stage biopharmaceutical company focused on therapies for systemic sclerosis, today announced results from its Phase 2 RECONNOITER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results